• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

J Comput Biol . From Alpha to Zeta: Identifying Variants and Subtypes of SARS-CoV-2 Via Clustering

tetano

Editor, Senior Moderator
J Comput Biol


. 2021 Oct 25.
doi: 10.1089/cmb.2021.0302. Online ahead of print.
From Alpha to Zeta: Identifying Variants and Subtypes of SARS-CoV-2 Via Clustering


Andrew Melnyk[SUP] 1 [/SUP], Fatemeh Mohebbi[SUP] 1 [/SUP], Sergey Knyazev[SUP] 1 [/SUP], Bikram Sahoo[SUP] 1 [/SUP], Roya Hosseini[SUP] 1 [/SUP], Pavel Skums[SUP] 1 [/SUP], Alex Zelikovsky[SUP] 1 2 [/SUP], Murray Patterson[SUP] 1 [/SUP]



Affiliations

Abstract

The availability of millions of SARS-CoV-2 (Severe Acute Respiratory Syndrome-Coronavirus-2) sequences in public databases such as GISAID (Global Initiative on Sharing All Influenza Data) and EMBL-EBI (European Molecular Biology Laboratory-European Bioinformatics Institute) (the United Kingdom) allows a detailed study of the evolution, genomic diversity, and dynamics of a virus such as never before. Here, we identify novel variants and subtypes of SARS-CoV-2 by clustering sequences in adapting methods originally designed for haplotyping intrahost viral populations. We asses our results using clustering entropy-the first time it has been used in this context. Our clustering approach reaches lower entropies compared with other methods, and we are able to boost this even further through gap filling and Monte Carlo-based entropy minimization. Moreover, our method clearly identifies the well-known Alpha variant in the U.K. and GISAID data sets, and is also able to detect the much less represented (<1% of the sequences) Beta (South Africa), Epsilon (California), and Gamma and Zeta (Brazil) variants in the GISAID data set. Finally, we show that each variant identified has high selective fitness, based on the growth rate of its cluster over time. This demonstrates that our clustering approach is a viable alternative for detecting even rare subtypes in very large data sets.

Keywords: clustering; entropy; fitness; genomic surveillance; viral subtypes; viral variants.
 
Back
Top Bottom